<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72303-0851-1
</NDCCode>
<PackageDescription>
1 BOTTLE, PLASTIC in 1 CARTON (72303-0851-1) / 60 mL in 1 BOTTLE, PLASTIC
</PackageDescription>
<NDC11Code>
72303-0851-01
</NDC11Code>
<ProductNDC>
72303-0851
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Oseltamivir Phosphate
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Oseltamivir Phosphate
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20260325
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA213594
</ApplicationNumber>
<LabelerName>
HEC Pharm USA Inc.
</LabelerName>
<SubstanceName>
OSELTAMIVIR PHOSPHATE
</SubstanceName>
<StrengthNumber>
6
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-03-27
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260325
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>